Accel Diagnostics

Accel Diagnostics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $21.2M

Overview

Accel Diagnostic Laboratories is a private, commercial-stage clinical laboratory services company focused on routine and specialized diagnostic testing for healthcare providers. It leverages a network of CLIA-certified and COLA-accredited labs equipped with state-of-the-art analyzers to serve physician practices, hospitals, urgent care centers, and skilled nursing facilities. The company's business model is built on providing faster turnaround times and a comprehensive test menu to support clinical decision-making. It appears to be an early-revenue, service-oriented diagnostics business rather than a developer of novel rapid test products, despite its founding name suggesting a product development focus.

Infectious DiseaseGeneral Diagnostics

Technology Platform

Operational laboratory platform utilizing commercial smart analyzers and a HIPAA-compliant laboratory information system (LIS) for efficient, high-quality diagnostic testing services.

Funding History

37
Total raised:$21.2M
Grant$750K
Grant$399K
Grant$2M
Grant$97K

Opportunities

The growing demand for fast, decentralized diagnostic testing from outpatient clinics, urgent care centers, and hospitals presents a significant opportunity.
Emphasizing 'STAT' turnaround times can differentiate Accel Lab in a market where speed impacts clinical decisions.
Expansion of its test menu into higher-complexity and esoteric tests could improve margins and client retention.

Risk Factors

Major risks include intense competition from large national laboratories, constant pressure on reimbursement rates from payers, and the high regulatory burden (CLIA, HIPAA) of operating a clinical lab.
The business is also susceptible to supply chain disruptions for reagents and analyzer equipment.

Competitive Landscape

Accel Lab operates in the highly competitive clinical laboratory services market, competing directly with national leaders Quest Diagnostics and LabCorp, as well as numerous regional and hospital-affiliated labs. Its differentiation is based on service speed, a broad test menu, and a regional focus, rather than proprietary test technology. It also competes with specialized toxicology and esoteric testing labs.